Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$625M Buy
5,228,925
+7,416
+0.1% +$972K 0.17% 113
2025
Q4
$711M Buy
5,221,509
+264,693
+5% +$38.1M 0.19% 112
2025
Q3
$739M Sell
4,956,816
-757,760
-13% -$105M 0.24% 78
2025
Q2
$731M Buy
5,714,576
+830,337
+17% +$101M 0.25% 77
2025
Q1
$557M Sell
4,884,239
-458,828
-9% -$56.9M 0.2% 105
2024
Q4
$620M Sell
5,343,067
-96,903
-2% -$12.3M 0.22% 103
2024
Q3
$731M Buy
5,439,970
+963,927
+22% +$129M 0.27% 88
2024
Q2
$598M Sell
4,476,043
-712,516
-14% -$96.9M 0.23% 99
2024
Q1
$663M Sell
5,188,559
-428,542
-8% -$51.8M 0.29% 77
2023
Q4
$635M Sell
5,617,101
-205,918
-4% -$20.6M 0.29% 80
2023
Q3
$527M Buy
5,823,019
+807,190
+16% +$83.3M 0.26% 90
2023
Q2
$562M Buy
5,015,829
+1,496,597
+43% +$158M 0.28% 84
2023
Q1
$358M Buy
3,519,232
+302,886
+9% +$31.6M 0.19% 130
2022
Q4
$366M Sell
3,216,346
-163,920
-5% -$17.2M 0.2% 127
2022
Q3
$309M Buy
3,380,266
+2,030,756
+150% +$185M 0.18% 140
2022
Q2
$102M Sell
1,349,510
-601,009
-31% -$49.6M 0.08% 258
2022
Q1
$168M Buy
1,950,519
+561,152
+40% +$53.8M 0.11% 207
2021
Q4
$161M Buy
1,389,367
+41,779
+3% +$5.19M 0.1% 221
2021
Q3
$167M Buy
1,347,588
+32,476
+2% +$4.18M 0.12% 204
2021
Q2
$158M Buy
+1,315,112
New +$150M 0.11% 203

Other funds holding XYL

Amundi's XYL Position: Q1 2026 in Review

Amundi increased its Xylem (XYL) stake by 0.14% in Q1 2026, buying an estimated $972K and bringing the position to 5,228,925 shares worth $625M. The position accounts for 0.17% of the portfolio, ranked #113.

Amundi first reported a position in XYL in Q2 2021 and has held it in 20 quarters since. The position peaked at $739M in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Amundi held 5,228,925 shares of Xylem worth $625M as of Q1 2026.
  • Amundi bought 7,416 Xylem shares in Q1 2026, an estimated $972K.
  • Xylem made up 0.17% of Amundi's portfolio in Q1 2026, its #113 holding.
  • Amundi first reported a position in Xylem in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Xylem position peaked at $739M in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.